Want to join the conversation?
$ESS 2Q15 Call: During the second quarter a combination of NOI growth and pull back in stock price caused our accretion hurdles for acquisition. Capital rates remain low throughout the market. We are quite sure that aggressive assumptions on buyer pro forma often indicate the cap rates are 50BPs or more above the cap rate.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?